Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications

Current Hematologic Malignancy Reports(2025)10.1007/s11899-024-00749-4Source: DataRank Database

Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications is a research paper published in Current Hematologic Malignancy Reports (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.79)OA: greenTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Merle Riedemann,Jonas S. Jutzi ORCID,Ann Mullally ORCID,Mifra Faiz ORCID

Live enrichment

PubMed:39775969 PMC:PMC12085081 OpenAlex:https://openalex.org/W4406133867

NIH NHLBI

Grant: R01HL131835

Department of Defense Congressionally Directed Medical Research Program

Grant: W81XWH2110909

Leukemia & Lymphoma Society

Grant: (LLS Discovery Grant ID: 8041-24

European Hematology Association

Grant: TRTH112

NHLBI NIH HHS

Grant: R01 HL167139

National Institutes of Health

Grant: 3R01HL167139-02S1

Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem Cells - Diversity Supplement

National Institutes of Health

Grant: 5R01HL131835-03

Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms

Starr Cancer Consortium

FWCI

3.79

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12085081/pdf/nihms-2076915.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11899-024-00749-4.pdf

publisherhttps://link.springer.com/article/10.1007/s11899-024-00749-4

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12085081

Fields of Study

Myeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesAcute Myeloid Leukemia Research0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansMutationMyeloproliferative DisordersSignal TransductionCalreticulinReceptors, ThrombopoietinMolecular Targeted Therapy

Keywords

CalreticulinMutantCancer researchBiologyCell biologyGeneticsGeneEndoplasmic reticulumMyeloproliferative DisordersMutationAnimalsHumansMolecular Targeted TherapySignal Transduction

Sustainable Development Goals

SDG 0: Zero hunger